BCL9

Description		BCL9 transcription coactivator
Image
GO Annotations	Cellular Component	Nucleoplasm Cis-Golgi Network Beta-catenin-TCF Complex
	Molecular Function	Transcription Coactivator Activity Protein Binding Beta-catenin Binding
	Biological Process	Myotube Differentiation Involved In Skeletal Muscle Regeneration Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway Somatic Stem Cell Population Maintenance Skeletal Muscle Cell Differentiation Positive Regulation Of Transcription By RNA Polymerase II Canonical Wnt Signaling Pathway
Pathways		Formation of the beta-catenin:TCF transactivating complex Deactivation of the beta-catenin transactivating complex
Drugs
Diseases
GWAS		Adult body size ( 32376654) Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU) ( 24025145) Schizophrenia (negative symptoms) ( 23382809) Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes ( 28736931) Type 2 diabetes ( 25760438)
Interacting Genes		4 interacting genes: CTNNB1 PYGO1 PYGO2 USP9X
Entrez ID		607
HPRD ID		04000
Ensembl ID		ENSG00000116128
Uniprot IDs		A0A024QYY4 O00512 Q1JQ81
PDB IDs		2GL7 2VP7 2VPB 2VPD 2VPE 2VPG 3SL9
Enriched GO Terms of Interacting Partners?
Tagcloud ?